(Alliance News) - GSK PLC on Tuesday said its Blenrep cancer treatment will undergo review in Japan after successful authorisations recently in the UK and Europe. Read More
(Alliance News) - GSK PLC on Friday announced that it has been granted breakthrough therapy designation in China for Blenrep, a treatment for relapsed or refractory multiple myeloma. Read More
(Alliance News) - GSK PLC on Thursday hailed a "significant advancement" as it reported positive findings from a trial on a possible flu vaccine. Read More
(Alliance News) - Stocks prices in London are called to open sharply higher on Thursday, after a rip-roaring climb for US tech shares overnight helped settle the mood in equities before a eurozone interest rate decision. Read More
(Alliance News) - London's FTSE 100 underperformed European peers, but headed into Wednesday afternoon just about in the green as a US inflation reading looms. Read More
(Alliance News) - GSK PLC on Wednesday said that its vaccine candidate for the herpes simplex virus did not meet a primary efficacy objective in testing, and will not progress to the next phase of studies. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and Friday and not separately reported by Alliance News: Read More
(Alliance News) - Stock prices in London were higher at midday on Thursday, as the market looks ahead to a handful of economic data from the US later today. Read More
(Alliance News) - GSK PLC on Thursday announced that the European Commission has authorised Arexvy, its respiratory syncytial virus vaccine, for adults aged 50 to 59 who are at increased risk. Read More
(Alliance News) - Stocks were called higher in London on Thursday morning, as investors wait for a handful of data from the US later, including the most recent GDP figures. Read More
(Alliance News) - Stock prices in Europe closed mixed on Wednesday, while equities in New York traded in a nervy fashion, as investors anxiously await earnings from chipmaker Nvidia. Read More
(Alliance News) - While Zantac worries are not completely resolved, the latest bit of good news for GSK PLC should give investors some reassurance, analysts said on Wednesday. Read More
(Alliance News) - GSK PLC on Wednesday announced progress in Japan on treating chronic hepatitis B and chronic rhinosinusitis with nasal polyps, while it welcomed a decision by the Delaware Supreme Court regarding heartburn drug Zantac. Read More
(Alliance News) - GSK PLC on Tuesday said a targeted antibody-drug conjugate received a breakthrough therapy designation from the US Food & Drug Administration. Read More
(Alliance News) - London's FTSE 100 ended a winning week on the back foot, but it was a brighter picture for sterling, while gold leapt again, hitting a new record high. Read More
(Alliance News) - A positive ruling in Florida state court regarding Zantac was seen as an "important" step towards clearing the litigation-related overhang that has dogged GSK PLC. Read More
(Alliance News) - Stock prices in London were drifting lower at midday on Friday, failing to muster much enthusiasm for the latest rise in UK retail sales. Read More
(Alliance News) - Stock prices in London opened lower on Friday, slipping a little in a quieter end to the week despite positive retail data for July. Read More